Bolin Liu
Impact in
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 15
- Histone Deacetylase Inhibitors Research 11
- Glycosylation and Glycoproteins Research 9
- Cell death mechanisms and regulation 9
- Metabolism, Diabetes, and Cancer 8
- Oncology 60
- HER2/EGFR in Cancer Research 30
- Cancer-related Molecular Pathways 14
- Co-authors
- Ann D. Thor (26 shared papers)Susan M. Edgerton (21 shared papers)Stuart E. Lind (6 shared papers)Zeying Fan (7 shared papers)Hui Lyu (25 shared papers)Yang Lü (8 shared papers)Zhen Fan (9 shared papers)Irina Alimova (2 shared papers)
- Journals
- Cancer Research (9 papers)Cell Cycle (8 papers)Oncogene (7 papers)Cancer Letters (5 papers)Breast Cancer Research (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Bolin Liu
148 papers receiving 7.2k citations
Peers
Comparison fields: 5 of 151
- Oncology 3.1k
- Cancer Research 1.6k
- Molecular Biology 4.5k
- Radiology, Nuclear Medicine and Imaging 851
- Genetics 333
Countries citing papers authored by Bolin Liu
This map shows the geographic impact of Bolin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolin Liu more than expected).
Fields of papers citing papers by Bolin Liu
This network shows the impact of papers produced by Bolin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolin Liu. The network helps show where Bolin Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Bolin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 157 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 430 | |
| 2 | 2003 | 378 | |
| 3 | 2009 | 337 | |
| 4 | 1998 | 299 | |
| 5 | 2011 | 240 | |
| 6 | 2005 | 218 | |
| 7 | 2011 | 209 | |
| 8 | 2010 | 191 | |
| 9 | Overexpression of c-erbB-2/neu in breast cancer cells confers increased resistance to Taxol via mdr-1-independent mechanisms. | 1996 | 182 |
| 10 | 2012 | 180 | |
| 11 | 1994 | 157 | |
| 12 | 2007 | 156 | |
| 13 | 2014 | 143 | |
| 14 | 2014 | 142 | |
| 15 | 2007 | 135 | |
| 16 | 2011 | 115 | |
| 17 | 2000 | 110 | |
| 18 | 2010 | 107 | |
| 19 | 2003 | 106 | |
| 20 | 2005 | 105 |
About Bolin Liu
Bolin Liu is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Genetics, having authored 157 papers that have together received 7.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (30 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), PI3K/AKT/mTOR signaling in cancer (15 papers), Cancer-related Molecular Pathways (14 papers), Histone Deacetylase Inhibitors Research (11 papers), Glycosylation and Glycoproteins Research (9 papers), Cell death mechanisms and regulation (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Oncology (3.1k citations), Cancer Research (1.6k citations), Molecular Biology (4.5k citations), Radiology, Nuclear Medicine and Imaging (851 citations) and Genetics (333 citations). Bolin Liu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Ann D. Thor, Susan M. Edgerton, Stuart E. Lind, Zeying Fan, Hui Lyu, Yang Lü, Zhen Fan, Irina Alimova, Jingcao Huang and Shuiliang Wang. Their work appears in journals such as Cancer Research, Cell Cycle, Oncogene, Cancer Letters and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.